RxDoctor Payments Data

Georgia Buckley, PA

Physician Assistant · Fayetteville, NCNPI 1205862547

Payments from drug & device makers

$2,405in general payments, 2019–2025

Across 127 payments — averaging $18.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$416
  • Lilly USA, LLC$383
  • Novo Nordisk$305
  • Abbott$242
  • Phathom Pharmaceuticals, Inc.$165
  • Amgen$154
  • plus $740 from 23 others

What the payments were for

  • Food & beverage$2,393100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,405 in reported general payments places this provider in the 80th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$25,037
Medicare patients
99
Services billed
378

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide86$103,762
TrulicityDulaglutide29$36,362
JanuviaSitagliptin Phosphate29$24,107
JardianceEmpagliflozin14$18,742
FarxigaDapagliflozin Propanediol20$18,147
EliquisApixaban11$7,985
Repatha SureclickEvolocumab13$7,335
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$2,902
Atorvastatin Calcium210$1,989
Omeprazole133$1,859
Gabapentin85$1,340
SynthroidLevothyroxine Sodium17$1,337
Rosuvastatin Calcium138$1,330
Albuterol Sulfate HfaAlbuterol Sulfate72$1,306
Doxepin Hcl11$1,287

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$305$103,76286 claims
Lilly USA, LLCTrulicity$383$36,36229 claims
Boehringer IngelheimJardiance$85$18,74214 claims
AstraZenecaFarxiga$416$18,14720 claims
PfizerEliquis$61$7,98511 claims
AbbVieSynthroid$31$1,33717 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Fayetteville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →